Pursuant to the provisions of Reg 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Regulations'), the Board of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Symbiox Investment & Trading Co. Ltd. held a meeting on 23rd May 2026 and approved the audited financial results for the quarter and year ended 31st March 2026. For the full year, the company reported total income of Rs 160.52 lakh and profit after tax of Rs 15.23 lakh, compared to Rs 276.79 lakh total income and Rs 19.19 lakh PAT in the previous year — indicating a decline in revenue and profitability year-on-year. The statutory auditors, SSRV & Associates, issued an unmodified opinion, meaning the financial statements are clean with no qualifications. The board also re-appointed Mr. Akhil Agarwal (Practising Company Secretary) as Secretarial Auditor and M/s Shikha Singhal & Associates (Chartered Accountants) as Internal Auditor for FY 2026-27. Total equity stands at Rs 3,187.63 lakh with total assets of Rs 3,197.60 lakh.
The company posted a modest profit of Rs 15.23 lakh for FY 2026, but revenue nearly halved compared to the prior year, signalling weaker operational performance. The clean audit opinion is a positive signal, though the top-line decline may concern investors focused on growth. The re-appointment of both auditors suggests continuation of compliance governance.